HC Deb 19 April 2004 vol 420 cc173-4W
Dr. Gibson

To ask the Secretary of State for Health (1) pursuant to his answer of 5 January 2004,Official Report, column 200W, on the National Institute for Clinical Excellence, when the findings of the investigation into the implementation of guidance on the use of cancer treatments produced by the National Institute for Clinical Excellence will be published; [164239]

Mr. Evans

To ask the Secretary of State for Health (2) when the National Cancer Director expects to have completed his review of postcode prescribing in the case of cancer treatment. [R] [164683]

Miss Melanie Johnson

Professor Mike Richards, the National Cancer Director, is continuing his investigation into the causes of the apparent variation in the uptake of cancer drugs approved by the National Institue for Clinical Excellence.

Professor Richards is currently considering evidence provided by the 34 cancer networks in England and data supplied by the pharmaceutical industry.

Findings are expected to be available in Spring 2004.

Forward to